Role of Transporters in the Disposition of the Selective Phosphodiesterase-4 Inhibitor (+)-2-[4-({[2-(Benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic Acid in Rat and Human
KALGUTKAR, Amit S, BO FENG, DUIGNAN, David B, CHOO, Edna F, ZHAO, Sabrina X, NGUYEN, Hang T, FREDERICK, Kosea S, CAMPBELL, Scott D, HATCH, Heather L, BI, Yi-An, KAZOLIAS, Diana C, DAVIDSON, Ralph E, MIRELES, Rouchelle J
Published in Drug metabolism and disposition (01.11.2007)
Published in Drug metabolism and disposition (01.11.2007)
Get full text
Journal Article
Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility
Kalgutkar, Amit S., Frederick, Kosea S., Hatch, Heather L., Ambler, Catherine M., Perry, David A., Garigipati, Ravi S., Chang, George C., Lefker, Bruce A., Clark, Ronald W., Morehouse, Lee A., Francone, Omar, Hu, Xiao
Published in Xenobiotica (01.07.2014)
Published in Xenobiotica (01.07.2014)
Get full text
Journal Article
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38α inhibitor: identification of an active metabolite in preclinical species and human liver microsomes
Kalgutkar, Amit S., Hatch, Heather L., Kosea, Frederick, Nguyen, Hang T., Choo, Edna F., McClure, Kim F., Taylor, Timothy J., Henne, Kirk R., Kuperman, Alexander V., Dombroski, Mark A., Letavic, Michael A.
Published in Biopharmaceutics & drug disposition (01.11.2006)
Published in Biopharmaceutics & drug disposition (01.11.2006)
Get full text
Journal Article
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes
Kalgutkar, Amit S, Hatch, Heather L, Kosea, Frederick, Nguyen, Hang T, Choo, Edna F, McClure, Kim F, Taylor, Timothy J, Henne, Kirk R, Kuperman, Alexander V, Dombroski, Mark A, Letavic, Michael A
Published in Biopharmaceutics & drug disposition (01.11.2006)
Get full text
Published in Biopharmaceutics & drug disposition (01.11.2006)
Journal Article
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5- difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyr idine , a novel and selective p38 alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes
Kalgutkar, Amit S, Hatch, Heather L, Kosea, Frederick, Nguyen, Hang T, Choo, Edna F, McClure, Kim F, Taylor, Timothy J, Henne, Kirk R, Kuperman, Alexander V, Dombroski, Mark A, Letavic, Michael A
Published in Biopharmaceutics & drug disposition (01.01.2006)
Published in Biopharmaceutics & drug disposition (01.01.2006)
Get full text
Journal Article
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3 -isopropyl -[1,2,4 ] -triazolo [4,3-a] pyridine, a novel and selective p38a inhibitor : Identification of an active metabolite in preclinical species and human liver microsomes
KALGUTKAR, Amit S, HATCH, Heather L, LETAVIC, Michael A, KOSEA, Frederick, NGUYEN, Hang T, CHOO, Edna F, MCCLURE, Kim F, TAYLOR, Timothy J, HENNE, Kirk R, KUPERMAN, Alexander V, DOMBROSKI, Mark A
Published in Biopharmaceutics & drug disposition (2006)
Get full text
Published in Biopharmaceutics & drug disposition (2006)
Journal Article